JMDC Inc
TSE:4483

Watchlist Manager
JMDC Inc Logo
JMDC Inc
TSE:4483
Watchlist
Price: 3 335 JPY -0.89% Market Closed
Market Cap: ¥218.2B

P/E

26.5
Current
48%
Cheaper
vs 3-y average of 50.8

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
26.5
=
Market Cap
¥265.6B
/
Net Income
¥8.2B

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
26.5
=
Market Cap
¥265.6B
/
Net Income
¥8.2B

Valuation Scenarios

JMDC Inc is trading below its 3-year average

If P/E returns to its 3-Year Average (50.8), the stock would be worth ¥6 382.47 (91% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-36%
Maximum Upside
+152%
Average Upside
46%
Scenario P/E Value Implied Price Upside/Downside
Current Multiple 26.5 ¥3 335
0%
3-Year Average 50.8 ¥6 382.47
+91%
5-Year Average 66.8 ¥8 398.77
+152%
Industry Average 20.7 ¥2 606.67
-22%
Country Average 17 ¥2 138.15
-36%

Forward P/E
Today’s price vs future net income

Today's Market Cap Net Income Forward P/E
¥265.6B
/
Jan 2026
¥8.2B
=
26.5
Current
¥265.6B
/
Mar 2026
¥7.6B
=
35.1
Forward
¥265.6B
/
Mar 2027
¥9.6B
=
27.8
Forward
¥265.6B
/
Mar 2028
¥12B
=
22.1
Forward

Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.

Peer Comparison

All Countries
Close

Market Distribution

Higher than 78% of companies in Japan
Percentile
78th
Based on 5 185 companies
78th percentile
26.5
Low
0 — 13.1
Typical Range
13.1 — 23
High
23 —
Distribution Statistics
Japan
Min 0
30th Percentile 13.1
Median 17
70th Percentile 23
Max 7 956 708

JMDC Inc
Glance View

Market Cap
218.2B JPY
Industry
Health Care

Amidst the complex intersection of healthcare and technology, JMDC Inc. has carved a unique niche by harnessing the power of big data to improve healthcare outcomes and efficiency. Founded in Japan, the company stands as a beacon in the health informatics sector, meticulously collecting and analyzing health-related data drawn from a variety of sources, including medical claims, health screenings, and electronic health records. By transforming this extensive data trove into actionable insights, JMDC offers healthcare providers, pharmaceutical companies, and insurance firms the analytics they need to make informed decisions. Key to JMDC's operation is its commitment to safeguarding patient anonymity while extracting valuable insights that can streamline healthcare delivery, enhance pharmaceutical research, and optimize insurance underwriting. JMDC's revenue model hinges on the sale of its aggregated data and analytics solutions to a vast array of stakeholders in the medical field. Pharmaceutical companies, eager to understand drug efficacy and patient demographics better, turn to JMDC for data-driven insights that can influence drug development and marketing strategies. Insurance companies leverage JMDC's data to refine their offerings and better assess risk, ensuring competitive pricing models and improved customer satisfaction. Moreover, healthcare providers utilize this analytics backbone to enhance operational efficiency and improve patient care outcomes. Through licensing agreements and subscription-based services, JMDC effectively monetizes its data resources, achieving sustained growth in an industry that increasingly values the marriage of technology and healthcare.

Intrinsic Value
3 968.52 JPY
Undervaluation 16%
Intrinsic Value
Price ¥3 335
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett